Google DeepMind Launches AI Tool to Analyze Human Genome Variants
Google DeepMind has introduced a new AI-powered platform called AlphaGenome Atlas, designed to predict the molecular effects of nearly nine billion possible single-letter DNA substitutions in the human genome. The tool aims to help scientists identify which genetic changes are significant for disease and biology by providing detailed insights into how these variants might influence protein production or gene regulation. The project builds on DeepMind’s previous AI models, such as AlphaGenome and AlphaMissense, but expands their scope across the entire genome—including non-coding regions. A new Variant Impact Score (AVI) is also introduced to help researchers prioritize which mutations are most relevant for further study. The dataset generated by Atlas is approximately 1 petabyte in size. Google plans to make the tool available through a web portal and its cloud services, initially for non-commercial use with commercial access coming soon.
Tickers: $GOOGL
Topics: AI AlphaFold DeepMind Genome Research Medical Innovation